*Some Market data delayed by 15 mins.

VYNE Therapeutics Inc. Common Stock

Symbol: VYNE (NASDAQ)
2.05 ▼ (-0.97%) -0.020

Company Description:
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Key Stats
  • Today's Open: $2.08
  • Today's High: $2.131
  • Today's Low: $2.05
  • Today's Volume: 54.89K
  • Yesterday Close: $2.07
  • Yesterday High: $2.1
  • Yesterday Low: $1.9
  • Yesterday Volume: 83.82K
  • Last Min Volume: 200
  • Last Min High: $2.05
  • Last Min Low: $2.05
  • Last Min VWAP: $2.05
Company Profile
  • Name: VYNE Therapeutics Inc. Common Stock
  • Website: https://www.vynetherapeutics.com
  • Listed Date: 2018-01-25
  • Location: BRIDGEWATER, NJ
  • Market Status: Active
  • CIK Number: 0001566044
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $31.09M
  • Round Lot: 100
  • Outstanding Shares: 14.53M
  • Asset Type: CS
RECENT FILINGS FOR VYNE
Filing DateFiling TypeFormat
2024-07-034View
2024-07-034View
2024-07-034View
2024-07-034View
2024-06-044View
2024-05-0910-QView
2024-05-098-KView
2024-04-034View
2024-04-034View
2024-04-034View
2024-04-034View
2024-03-14EFFECTView
2024-03-12CORRESPView
2024-03-06UPLOADView
2024-03-01S-3View
2024-03-01S-8View
2024-03-0110-KView
2024-02-298-KView
2024-02-14SC 13G/AView
2024-02-02SC 13G/AView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.